Home intravenous antibiotic therapy (HIVAT): indications, patients and antimicrobial agents

https://doi.org/10.1016/0924-8579(94)00046-WGet rights and content

Abstract

Concern regarding escalating costs of inhospital intravenous (i.v.) antibiotic treatment has stimulated interest in providing i.v. antibiotic therapy in outpatient or home settings (HIVAT). HIVAT should be considered when patients no longer need careful observation and daily nursing care. Successful HIVAT can be accomplished utilizing a team approach emphasizing the respective roles of the physician, pharmacist, nurse and patient. This paper is based on a retrospective review of approximately 1500 patients (19 500 days of HIVAT), treated between 1978 and 1993, in a hospital-based programme. This review addresses which infectious diseases can be treated with HIVAT, with special emphasis on patient and antibiotic selection criteria and the importance of patient monitoring and preliminary data on the outcomes of such therapy.

References (27)

  • P Francioli et al.

    Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for four weeks. Efficacy and outpatient treatment feasibility

    JAMA

    (1992)
  • W Balinsky

    Reimbursement for outpatient parenteral antibiotic therapy: update

    Rev Infect Dis

    (1991)
  • A Antoniskis et al.

    Feasibility of outpatient self-administration of parenteral antibiotics

    West J Med

    (1978)
  • Cited by (0)

    Tel. (+1-612) 347 3416: Fax: 1 612 347 2003.

    View full text